Mariner Investment Group’s Gilead Sciences GILD Stock Holding History

Mariner Investment Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-64,100	Closed	-$5.35M	–	98
2016 Q2	$5.35M	Sell	64,100 -51,200	-44%	-$4.54M	1.81%	20
2016 Q1	$10.6M	Buy	115,300 +31,000	+37%	+$2.8M	2.92%	3
2015 Q4	$8.53M	Buy	84,300 +7,000	+9%	+$728K	1.9%	8
2015 Q3	$7.59M	Buy	77,300 +10,000	+15%	+$1.11M	1.53%	13
2015 Q2	$7.88M	Sell	67,300 -17,600	-21%	-$1.92M	2.01%	5
2015 Q1	$8.33M	Buy	84,900 +39,000	+85%	+$3.96M	2.24%	7
2014 Q4	$4.33M	Buy	45,900 +31,500	+219%	+$3.26M	0.74%	36
2014 Q3	$1.53M	Sell	14,400 -38,700	-73%	-$3.79M	0.32%	77
2014 Q2	$4.4M	Buy	53,100 +25,100	+90%	+$1.95M	0.85%	27
2014 Q1	$1.98M	Buy	+28,000	New	+$2.2M	0.44%	55

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mariner Investment Group's GILD Position: Q3 2016 in Review

Mariner Investment Group sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 64,100 shares — an estimated $5.35M sold.

Mariner Investment Group first reported a position in GILD in Q1 2014 and held it in 10 quarters. The position peaked at $10.6M in Q1 2016. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Mariner Investment Group reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
Mariner Investment Group sold 64,100 Gilead Sciences shares in Q3 2016, an estimated $5.35M.
Mariner Investment Group first reported a position in Gilead Sciences in Q1 2014 and held it in 10 quarters.
Mariner Investment Group's Gilead Sciences position peaked at $10.6M in Q1 2016.
1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.